New

Senior Scientist, Analytical CMC

Millbrae, CA

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.

Position Overview:

The Senior Scientist, CMC Analytical Lead provides analytical leadership for assigned drug substance and drug product programs from IND-enabling studies through clinical development, registration, and commercial readiness. This role supports phase-appropriate analytical strategy and execution across key CMC activities, including IND-enabling, toxicology, early through late-stage clinical supply, drug substance process development, formulation and drug product development, and manufacturing. Responsibilities include analytical input to method readiness, transfer and validation strategy, release and stability strategy, shelf-life planning, specifications, data interpretation, and regulatory submissions.

This role is part of the CMC Analytical group and works closely with CMC, Quality, Regulatory, Supply Chain, and external CRO/CDMO partners to ensure analytical deliverables are scientifically sound, phase appropriate, and aligned with program needs. It includes hands-on analytical work, including method development and troubleshooting, while the primary focus remains program-level analytical leadership, risk assessment, cross-functional coordination, and oversight of internal and external analytical activities.

As part of a growing CMC Analytical team, this position offers strong opportunity for career advancement, direct impact on development programs, and continued growth into broader analytical program leadership.

Responsibilities:

Serve as the CMC Analytical Lead for assigned drug substance and drug product programs, coordinating analytical activities, tracking deliverables, communicating risks, and supporting program milestones in collaboration with senior technical and cross-functional stakeholders.

Support analytical method development, troubleshooting, qualification, transfer, and validation for drug substance, intermediates, raw materials and drug product, as appropriate for the stage of development.

Provide hands-on or laboratory-facing analytical support for non-GMP sample analysis for creation of CoA, method development, troubleshooting, investigation support, data interpretation, and resolution of technical issues during development, transfer, validation, release, or stability testing.

Provide scientific oversight of CRO/CDMO analytical activities, including review of methods, protocols, reports, deviations, investigations, data summaries, and timelines to ensure quality, scientific soundness, and phase-appropriate execution.

Contribute to phase-appropriate analytical control strategies, including specifications, method readiness, reference standards, impurity control, stability strategy, shelf-life planning and stability trending, and justification of analytical approaches with guidance from senior CMC, Quality, Regulatory, and program stakeholders as appropriate.

Collaborate with Research, Drug Substance, Drug Product, Regulatory Affairs, Quality Assurance, Manufacturing, Supply Chain, and Clinical Operations to ensure analytical deliverables support development, clinical supply, regulatory filings, and program decision-making.

Author, review, and contribute to analytical technical documents and regulatory submission content, including development reports, qualification or validation protocols and reports, specifications, stability summaries, shelf-life assessments, INDs, IMPDs, NDAs, and responses to regulatory questions.

Proactively identify analytical risks, propose mitigation strategies, communicate recommendations clearly, and provide technical guidance to junior staff or external collaborators as appropriate.

Qualifications:

Required Qualifications:

Degree in analytical chemistry, chemistry, pharmaceutical sciences, or a related discipline, with typical overall experience of Ph.D. 5+ years, M.S. 14+ years, or B.S. 16+ years, including directly relevant experience in analytical development, ARD, or CMC analytical support across Phase 1 through commercialization; approximately 5–6+ years of directly relevant experience is expected for M.S.-level candidates and 10+ years for B.S.-level candidates. Equivalent combinations of education and relevant experience may be considered.

Experience supporting drug substance and/or drug product analytical development, including method readiness, release and stability testing, data interpretation, and phase-appropriate documentation for clinical through registration stages.

Working knowledge of analytical techniques used in pharmaceutical development, such as HPLC/UPLC, dissolution, GC, LC-MS, KF, spectroscopy, solid-state characterization, and compendial methods.

Hands-on experience with analytical method development, troubleshooting, qualification, transfer, or validation in a pharmaceutical development or regulated laboratory setting.

Understanding of phase-appropriate CMC expectations, GMP and non-GMP development environments, quality systems, and regulatory guidance for analytical procedures, validation, impurities, stability, shelf-life, and specifications.

Effective communication, collaboration, organization, and problem-solving skills, with the ability to manage multiple priorities and communicate scientific rationale to technical and cross-functional audiences.

Highly Desirable Qualifications:

Experience representing analytical development on cross-functional CMC program teams supporting IND-enabling activities, toxicology supply, early clinical supply, drug substance process development, formulation or drug product development, or later-stage development.

Experience contributing to analytical control strategy, specification development or justification, stability strategy, shelf-life planning, stability trending, or regulatory submission content.

Experience working with CROs/CDMOs or external testing laboratories, including technical oversight, documentation review, issue resolution, and timeline management.

Specific expertise in product- or process-specific analytical challenges, such as supporting drug substance process development, characterization and qualification efforts, impurity control, stability-indicating method strategy, dissolution, compendial testing, or analytical method development for oral solid dosage and/or injectable products.

This role offers the opportunity to contribute to analytical strategy and execution for innovative drug development programs. The successful candidate will be scientifically curious, collaborative, and able to translate analytical and CMC data into practical, phase-appropriate decisions.

 

At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including:​

  • 401k plan with company matching​
  • Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)​
  • Mental health and wellness benefits​
  • Weeklong summer and winter holiday shutdowns​
  • Generous paid time off and holiday policies​
  • Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies ​
  • Enhanced parental leave benefit​
  • Daily subsidized lunch program when on-site​

The expected salary range for this role is $154,000 to $185,850 depending on skills, competency, and the market demand for your expertise.

Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.

We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.

Apply for this job

*

indicates a required field

Resume/CV*

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf

Select...
Select...
Select...
Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Eikon Therapeutics’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury
Select...

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.

We use Greenhouse’s AI-powered Talent Matching tool to compare your application against our job requirements.

Learn more